Isolated Gastric Myeloid Sarcoma: A Case Report and Review of the Literature by Pankit Vachhani, Prithviraj Bose

Get full text

Updates in the management of polycythemia vera and essential thrombocythemia by Prithviraj Bose, Srdan Verstovsek

Get full text

Recent therapeutic advances in chronic lymphocytic leukemia [version 1; referees: 2 approved] by Prithviraj Bose, Varsha Gandhi

Get full text

MF management by Prithviraj Bose, Srdan Verstovsek

Get full text

JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future Perspectives by Prithviraj Bose, Srdan Verstovsek

Get full text

Momelotinib: an emerging treatment for myelofibrosis patients with anemia by Helen T. Chifotides, Prithviraj Bose, Srdan Verstovsek

Get full text

Selecting the optimal BTK inhibitor therapy in CLL: rationale and practical considerations by Alexandra R. Lovell, Nadya Jammal, Prithviraj Bose

Get full text

Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications by Aaron T. Gerds, Prithviraj Bose, Gabriela S. Hobbs, Andrew T. Kuykendall, Lynn M. Neilson, Jinlin Song, Barbara Klencke, Claire N. Harrison

Get full text

A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis by Jason Gotlib, John H. Baird, Tracy I. George, Cheryl Langford, Isabel Reyes, Justin Abuel, Cecelia Perkins, Kurt Schroeder, Prithviraj Bose, Srdan Verstovsek

Get full text

Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections by Chia-Yu Chiu, Teny M. John, Takahiro Matsuo, Sebastian Wurster, Rachel S. Hicklen, Raihaan Riaz Khattak, Ella J. Ariza-Heredia, Prithviraj Bose, Dimitrios P. Kontoyiannis

Get full text

P1037: CONSISTENCY OF PACRITINIB FOR SPLEEN AND SYMPTOM REDUCTION IN PATIENTS WITH MYELOFIBROSIS REGARDLESS OF CYTOPENIAS by Nico Gagelmann, Vikas Gupta, Donal P Mclornan, Prithviraj Bose, Pankit Vachhani, Haifa Kathrin Al-Ali, Haris Ali, Philipp Treskes, Sarah Buckley, Karisse Roman-Torres, Bart Scott

Get full text

Interferons in the treatment of myeloproliferative neoplasms by Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M. Palmer, Aaron T. Gerds, Lucia Masarova, Andrew T. Kuykendall, Raajit K. Rampal, Ruben Mesa, Srdan Verstovsek

Get full text

Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells by Warren Fiskus, Taghi Manshouri, Christine Birdwell, Christopher P. Mill, Lucia Masarova, Prithviraj Bose, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Joseph D. Khoury, Srdan Verstovsek, Kapil N. Bhalla

Get full text

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation by Samer A. Srour, Amanda Olson, Stefan O. Ciurea, Parth Desai, Qaiser Bashir, Betul Oran, Prithviraj Bose, Rohtesh Mehta, Keyur P. Patel, Naveen Pemmaraju, Naval Daver, Srdan Verstovsek, Richard E. Champlin, Uday R. Popat

Get full text

P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLA... by Justin M. Watts, Anthony M. Hunter, Alessandra Iurlo, Blanca Xicoy, Francesca Palandri, Brandi Reeves, Alessandro Vannucchi, Prithviraj Bose, Rosa Ayala Diaz, Anna B. Halpern, Xuejun Chen, Francis Seguy, Feng Zhou, Fred Zheng, Pankit Vachhani

Get full text

P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SAFETY OF PELABRESIB (CPI-0610) AS ADD-ON TO RUXOLITINIB IN MYELOFIBROSIS by Marina Kremyanskaya, Claire Harrison, Prithviraj Bose, Vikas Gupta, Raajit K Rampal, Jonathan Lambert, Moshe Talpaz, Alessandro Vannucchi, Andrew Kuykendall, Jean-Jacques Kiladjian, Srdan Verstovsek, Ruben Mesa, Gozde Colak, Sandra Klein, Carmelita Alvero, John Mascarenhas

Get full text

P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE... by Prithviraj Bose, Sanjay Mohan, Stephen Oh, Jason Gotlib, Ellen Ritchie, Taizo Shimomura, Haris Ali, Francoise Boyer, Paola Guglielmelli, Anthony M. Hunter, Betty Lamothe, Yi Cui, Francis Seguy, Amanda Mcbride, Francesca Palandri, Masahiro Takeuchi, Jean-Jacques Kiladjian

Get full text

P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. by Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju, Mackenzie Dobbins, Nitin Jain, Hussein Abbas, Steven Kornblau, Abhishek Maiti, Ivo Veletic, Taghi Manshouri, Sharon Bledsoe, Mary Ann Richie, Nakiuda Hall-Moore, Lingsha Zhou, Xuemei Wang, Hagop Kantarjian, Zeev Estrov, Srdan Verstovsek

Get full text

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia by Prajwal Boddu, Gautam Borthakur, Mythili Koneru, Xuelin Huang, Kiran Naqvi, William Wierda, Prithviraj Bose, Elias Jabbour, Zeev Estrov, Jan Burger, Yesid Alvarado, April Deshmukh, Ami Patel, Antonio Cavazos, Lina Han, Jorge E. Cortes, Hagop Kantarjian, Michael Andreeff, Marina Konopleva

Get full text

A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial by Srdan Verstovsek, Moshe Talpaz, Martha Wadleigh, Alessandro Isidori, Peter te Boekhorst, Michael R. Savona, Prithviraj Bose, Olga Pozdnyakova, Ruben Mesa, Tarec C. El-Galaly, Jennifer O’Sullivan, Katia Gamel, Brian Higgins, Sudhakar Katakam, Boyan Todorov, Kerstin Trunzer, Claire N. Harrison

Get full text